WCN26-3375 NEUROFILAMENT LIGHT CHAIN AND COGNITIVE DYSFUNCTION IN PATIENTS UNDERGOING HEMODIALYSIS

Read full text Summarise with VIRAT
Authors: Kazuhiko Kato, Akio Nakashima, Arisa Kobayashi, Ichiro Ohkido, Takashi Yokoo
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Neurofilament light chain (NfL) levels have been used to prognosticate changes in cognitive function alongside the amyloid beta 1-42/1-40 (Aβ1-42/1-40) ratio. Nevertheless, this has not been studied in patients with chronic kidney disease, particularly those undergoing hemodialysis.

Fields of Study & Subjects

Dialysis and Renal Disease Management Dementia and Cognitive Impairment Research Neurological Disease Mechanisms and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104211–104211
Publication date
25 March 2026
Language
EN